Research use only Batch-level traceability HPLC / COA documentation workflow Peptides, blends and lab solutions
Bioregulators

Vesugen

Short Regulatory Peptide for Endothelial and vascular-pathway gene-expression models research models, supplied as lyophilized powder for qualified laboratory review.

+99% Purity Third-Party Tested COA Available
Available Presentations

Selected: 10 mg. Mention the exact presentation when requesting documentation.

Purity>99%
BatchVG028-060626
FormLyophilized Powder
Pack10 Vials

Technical Specifications

Primary analytical and handling data aligned to the current product record.

Molecular Formula C15H26N4O8
Molecular Weight 390.39 g/mol
Sequence

To be confirmed by batch COA

Product FormLyophilized Powder
Presentation10 mg / 10 Vials
Batch NumberVG028-060626
TestingHPLC purity verification; third-party COA recommended for final release
AppearanceWhite to off-white lyophilized powder
StorageStore according to batch COA and internal laboratory SOP. Protect from light and avoid repeated freeze-thaw cycles where applicable.
Research UseResearch Use Only (RUO)

Research FAQ — Vesugen

Frequently asked questions about this compound for laboratory researchers.

What is Vesugen?

This page lists the research-use profile, presentation range, technical specifications, and batch-aligned documentation path for this compound.

How should documentation be requested?

Use the exact compound name, presentation, and batch number when requesting a certificate or availability confirmation.

Which presentation should I reference?

Always reference the specific amount shown in the presentation selector and match it to the corresponding batch record.

How should Vesugen be stored?

Follow the storage conditions listed in the Technical Specifications section and batch documentation.